Intellia Therapeutics’ lonvo-z uses CRISPR to inactivate a gene in the liver to reduce levels of a protein key to the swelling attacks from the rare disease hereditary angioedema. Intellia has filed a regulatory submission for this genetic medicine, which could become the first in vivo gene-editing therapy to land FDA approval. The post Intellia’s…
Optain says partnership with EyePACS will allow for expanded access to retinal screening in primary care
Health coverage enrollment through the Affordable Care Act (ACA) marketplaces now exceeds 24 million people, a dramatic increase in recent years fueled largely by enhanced premium aid, which started in 2021 as part of the American Rescue Plan Act and extended through 2025 under the Inflation Reduction Act. But, with the subsidies set to expire…More
Physician leader TJ Redington outlines the advantages of CINs for provider leaders
Solera has created framework for responsible and transparent use of AI in digital health for use across its partner ecosystem
Though anselamimab failed its Phase 3 test in light chain amyloidosis, AstraZeneca points to encouraging results in a pre-defined patient subgroup — which may not be a winning strategy. Prothena resurrected its failed drug candidate for the disease based on a subgroup analysis, only to see that antibody fall short in a pivotal study. The…
This brief examines key characteristics of part-time workers and their access to coverage. Part-time workers are much less likely than full time ones to be offered health benefits by their employer or to have health coverage at all.
John Zutter is the CEO of Lantern Care which is a company managing specialty care. It has evolved from a centers of excellence model, and changed its name from Employers Direct earlier this year. The trick is product expansion into the expensive stuff, especially cancer care, infusion and specialty surgery. John has thought a lot…
A large study from Massachusetts has found that babies whose mothers had covid-19 while pregnant were slightly more likely to have a range of neurodevelopmental diagnoses by age 3. Most of these children had speech or motor delays, and the link was strongest in boys and when the mother was infected late in pregnancy. The…